By reporting this new way that future antivenoms can fail, the research has highlighted a problem with current antivenom testing recommendations.
Academic rigour, journalistic flair
Articles on Antibodies
Displaying 1 - 20 of 129 articles
The RSV shot children in WA will get is a monoclonal antibody. Here’s what that means.
We’re still using century-old technology to make snake antivenom. A method fit for the 21st century is on the horizon.
Viruses can get into cells in several ways. Figuring out how to stop them from entering in the first place is a key to developing better vaccines and stopping future pandemics.
The bacterium that causes Lyme disease is a master of disguise, changing its appearance to evade the immune system as it moves from the ticks that carry it to humans or animals.
COVID-19 vaccination has been shown to be safe in pregnancy, and protects both the mother and infant from severe disease. It’s now also clear that infants’ antibody protection continues after birth.
There’s pretty much no one left in the US who hasn’t been exposed to the coronavirus, whether by vaccination, infection or both.
The pandemic spurred the diagnostics industry to consider aspects like scale, affordability, speed and portability of tests.
An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge for researchers.
Inflammation is a complicated and important part of how the immune system responds to threats to the body. But when the inflammatory response goes awry, it can lead to serious problems.
A new species of bacteria that doesn’t normally live in the gut may trigger an immune response so strong that it spreads to the joints.
Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.
When COVID-19 and the flu co-infect, it’s ‘flurona.’ But such cases are rare, and there are effective ways to protect yourself from both viruses.
Evidence is growing there are changes to your immune system that may put you at risk of other infectious diseases.
A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.
Listeria causes serious illness and food recalls nearly every year.
To help people make informed decisions about ongoing COVID-19 risks, public health messaging needs to adapt as the pandemic evolves, just as immune systems adapt to new viruses and variants.
Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans having had COVID-19 by the end of February 2022.
Research suggests that too-frequent immunizations may lead to a phenomenon called “immune exhaustion.”
Evusheld is an antibody drug from AstraZeneca intended to help prevent COVID-19 infection for immunocompromised and other vulnerable patients.
Top contributors
-
Professor of Medicine, University of Virginia
-
Instructor of Human Immunology, Emory University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Associate Professor of Biology, Rochester Institute of Technology
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Senior Lecturer; MD, Victoria University
-
Emeritus Professor, Brunel University London
-
Senior Lecturer in Biomedical Sciences, Brunel University London
-
Program Director, Infectious Diseases and Immunology, Menzies Health Institute, Griffith University
-
Professor, Biomedicine Discovery Institute, Monash University
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Assistant Professor of Medicine, University of Virginia
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
